Cross Country Healthcare Sees Q1 EPS $0.15-$0.25 Vs $0.30 Est.; Revenue $370M-$380M Vs $399.04M Est.
Portfolio Pulse from Benzinga Newsdesk
Cross Country Healthcare (CCRN) provided its Q1 2024 earnings guidance, projecting EPS of $0.15-$0.25, below the $0.30 estimate, and revenue of $370M-$380M, under the $399.04M estimate. The company anticipates significant year-over-year and sequential declines in revenue, adjusted EBITDA, and adjusted EPS.
February 21, 2024 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cross Country Healthcare projects lower Q1 2024 earnings and revenue, with EPS of $0.15-$0.25 against a $0.30 estimate, and revenue of $370M-$380M versus a $399.04M estimate.
The projected earnings and revenue for Q1 2024 are significantly below analyst estimates and indicate a substantial year-over-year and sequential decline. This negative outlook is likely to impact investor sentiment and could lead to a decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100